PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

India’s CRDMO sector growth potential at $22 – $25 Billion by 2035, driving global pharma innovation: BCG-IPSO Report

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India's position in the global pharmaceutical value-chain Report states that India's CRDMO sector ...
Continue Reading →
News

Common Drug Shows Promise against Rare Type of Heart Disease

A research team co-led by scientists at the University of Arizona College of Medicine - Tucson found that an osteoporosis drug might counter a rare genetic mutation ...
Continue Reading →
News

Designing Self-Destructing Bacteria to Make Effective Tuberculosis Vaccines

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that ...
Continue Reading →
News

GSK Completes Acquisition of IDRx, Inc.

GSK plc (LSE/NYSE: GSK) announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, clinical-stage biopharmaceutical company dedicated to d...
Continue Reading →
News

Pharma’s Turn to Peer-to-Patient Platforms and Trusted Patient Communities

Jen Butler, Chief Commercial Officer for Pleio, discussed the significant threat of misinformation to public health, citing a 2021 report by former Surgeon General M...
Continue Reading →
News

Pharma urges NHS to Put Medicines at Heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England – down 10% in recent years – will undermine the government's efforts to rebuild t...
Continue Reading →
News

Coronado Research Announce the Appointment of Stephen Ralston as EVP Market Access and HEOR

Coronado Research, a consultancy-led, professional services organisation providing support to pharmaceutical, biotechnology, and medical device companies, has appoin...
Continue Reading →
News

Uniting Pharma Experts Worldwide: What to Expect at PHARMAP 2025

PHARMAP 2025 brings together experts from all over the world in Berlin, Germany on 14-15 April to share how to make medicine smarter and safer. Leading pharmaceutica...
Continue Reading →
News

Pfizer Believes in the Metaverse: Will Healthcare Thaw the Technology’s Winter?

The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential. The metaverse has faded from buzzword to...
Continue Reading →
News

Health Canada Approves Novartis’ Fabhalta for PNH with Haemolytic Anaemia

The decision is supported by findings from the Phase III APPLY-PNH trial. Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as the first ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026